{
  "kind": "treatment",
  "slug": "idebenone",
  "type": "nootropic",
  "name": "Idebenone",
  "summary": "A synthetic analog of coenzyme Q10 with antioxidant properties, studied for neuroprotection and mitochondrial disorders.",
  "description": "Idebenone is a short-chain synthetic benzoquinone and an analog of coenzyme Q10 (ubiquinone). It acts as an antioxidant and electron carrier in the mitochondrial electron transport chain. It has been studied for various neurological conditions, including Alzheimer's disease, Friedreich's ataxia, and other mitochondrial disorders, though psychiatric uses are mostly experimental.",
  "category": "medications/nootropics",
  "tags": [
    "nootropic",
    "antioxidant",
    "mitochondrial"
  ],
  "metadata": {
    "drug_classes": [
      "Nootropic",
      "Antioxidant"
    ],
    "therapeutic_categories": [
      "Neuroprotection",
      "Mitochondrial Disorders"
    ],
    "mechanism_categories": [
      "Other"
    ],
    "administration_routes": [
      "Oral"
    ],
    "prescription_status": "Varies by country",
    "controlled_substance": false,
    "generic_available": false,
    "brand_names": [
      "Catena",
      "Raxone"
    ],
    "dea_schedule": null,
    "fda_pregnancy_category": "Not assigned",
    "age_groups": [
      "Adult",
      "Geriatric",
      "Pediatric (select conditions)"
    ],
    "treatment_duration": [
      "Long-term"
    ],
    "specialty_areas": [
      "Neurology",
      "Mitochondrial Medicine"
    ],
    "fda_approval_year": 1986
  },
  "clinical_metadata": {
    "primary_indications": [
      "Other",
      "Pain"
    ],
    "off_label_uses": [
      "Alzheimer's disease",
      "Parkinson's disease",
      "Multiple sclerosis-related fatigue"
    ],
    "contraindications": [
      "Hypersensitivity to idebenone or excipients"
    ],
    "monitoring_required": [
      "Liver function tests in long-term use",
      "Clinical symptom monitoring"
    ],
    "efficacy_rating": {
      "neuroprotection": 3,
      "cognitive_enhancement": 2
    }
  },
  "search_metadata": {
    "searchable_terms": [
      "idebenone",
      "catena",
      "raxone",
      "coenzyme q10 analog"
    ],
    "synonyms": [
      "hydroxydecyl benzoquinone"
    ],
    "common_misspellings": [
      "idebanone",
      "idibenone"
    ]
  },
  "sections": [
    {
      "type": "indications",
      "items": [
        "Friedreich's ataxia (approved in EU)",
        "Leber's hereditary optic neuropathy (approved in EU)",
        "Experimental use in neurodegenerative disorders"
      ]
    },
    {
      "type": "mechanism",
      "text": "Functions as a synthetic analog of coenzyme Q10, facilitating electron transport in the mitochondrial respiratory chain and reducing oxidative stress."
    },
    {
      "type": "dosing",
      "adult": {
        "friedreichs_ataxia": "150â€“450 mg orally three times daily",
        "other": "Varies depending on study protocol"
      },
      "pediatric": "Dosage individualized based on indication",
      "hepatic_impairment": "Use with caution; no established adjustment",
      "renal_impairment": "No specific adjustment; monitor clinical status"
    },
    {
      "type": "dosage_forms",
      "items": [
        "Tablets: 150 mg",
        "Capsules: various strengths"
      ]
    },
    {
      "type": "onset_duration",
      "text": "Onset of clinical benefit may take several weeks to months; duration of action depends on continuous dosing."
    },
    {
      "type": "adverse_effects",
      "common": [
        "diarrhea",
        "nausea",
        "headache",
        "cough"
      ],
      "less_common": [
        "abdominal pain",
        "back pain",
        "insomnia"
      ],
      "serious": [
        "allergic reactions",
        "liver enzyme elevations"
      ]
    },
    {
      "type": "warnings",
      "black_box": null,
      "other": [
        "Limited evidence base for psychiatric or cognitive use",
        "Primarily approved for rare mitochondrial disorders in certain regions"
      ]
    },
    {
      "type": "interactions",
      "items": [
        {
          "with": "other antioxidants",
          "risk": "Unknown additive effects",
          "action": "Monitor clinical response"
        },
        {
          "with": "CYP450 substrates",
          "risk": "Possible metabolism alterations",
          "action": "Monitor if clinically significant"
        }
      ]
    },
    {
      "type": "monitoring",
      "items": [
        "Liver function tests",
        "Neurological symptom tracking",
        "Vision changes in optic neuropathy"
      ]
    },
    {
      "type": "special_populations",
      "pregnancy": "Use only if benefits outweigh risks; limited human data",
      "lactation": "Unknown excretion in breast milk; use caution",
      "pediatrics": "Used in certain rare genetic disorders; specialist oversight required",
      "geriatrics": "No specific adjustments; monitor for tolerability"
    },
    {
      "type": "tapering",
      "text": "No specific withdrawal effects expected; may discontinue without tapering."
    },
    {
      "type": "clinical_notes",
      "items": [
        "Antioxidant properties may have theoretical benefit in neurodegenerative disorders, but evidence is inconsistent",
        "Not FDA-approved in the U.S.",
        "EU approval for rare mitochondrial disorders; access may be restricted"
      ]
    },
    {
      "type": "references",
      "items": [
        {
          "label": "EMA Raxone Product Information",
          "url": "https://www.ema.europa.eu/"
        },
        {
          "label": "PubChem Idebenone",
          "url": "https://pubchem.ncbi.nlm.nih.gov/compound/Idebenone"
        }
      ]
    }
  ],
  "seo": {
    "title": "Idebenone: Synthetic Coenzyme Q10 Analog for Neuroprotection",
    "description": "Idebenone is an antioxidant and coenzyme Q10 analog approved for certain mitochondrial disorders, with potential neuroprotective effects."
  }
}
